Mueller Brian

BioMarin Pharmaceutical Inc.

EVP, Chief Financial Officer

Avg. Two Year Performance

No Purchase Track Record

(25%) Avg. Sale Return (12%) Compound

Holdings: 71.86K shares

Last Three Months: 04-Feb-24 -- 03-May-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Insider Trading Sentiment: Accumulate

Company Sentiment

Biotechnology

Drugs

Two Year Chart

04-May-22 -- 03-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions